Qing Li

Phase I Study and Biomarker Analysis of Pyrotinib, a Novel Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Fei Ma, Qiao Li, Shanshan Chen et al. · Journal of Clinical Oncology · 2017 · 234 citations

Medicine, Oncology, Pharmacology +17

Evidence That Breast Tissue Stiffness Is Associated with Risk of Breast Cancer

Norman F. Boyd, Qing Li, Olga Melnichouk et al. · PLoS ONE · 2014 · 152 citations · Full text

Medicine, Oncology, Radiology +15

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first‐line chemotherapy of HER2‐negative metastatic breast cancer

Xiuwen Guan, Fei Ma, Chunxiao Li et al. · Cancer Communications · 2019 · 114 citations · Full text

Medicine, Cancer Biology, Oncology +17

Evaluation of Contrast-enhanced US LI-RADS version 2017: Application on 2020 Liver Nodules in Patients with Hepatitis B Infection

Wei Zheng, Qing Li, Xuebin Zou et al. · Radiology · 2019 · 111 citations · Full text

Medicine, Radiology, Diagnostic Imaging +16

Differential expression of CD146 in tissues and endothelial cells derived from infantile haemangioma and normal human skin

Qing Li, Ying Yu, Joyce Bischoff et al. · The Journal of Pathology · 2003 · 102 citations

Medicine, Dermatology, Pathology +5